FGF23 and hyperphosphatemia: A reduced response to FGF-23 in the kidneys would blunt its phosphaturic effect and enhance intestinal phosphate absorption due to the inability of FGF-23 to inhibit vitamin D activation, thus perpetuating hyperphosphatemia and its adverse consequences [34].